Biorestorative Therapies (BRTX)
(Delayed Data from NSDQ)
$1.45 USD
+0.02 (1.40%)
Updated Aug 8, 2025 03:59 PM ET
After-Market: $1.44 -0.01 (-0.69%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BRTX 1.45 +0.02(1.40%)
Will BRTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BRTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BRTX
Zymeworks Inc. (ZYME) Tops Q2 Earnings and Revenue Estimates
Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates
BRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Lags Revenue Estimates
Stoke Therapeutics, Inc. (STOK) Tops Q1 Earnings and Revenue Estimates
Coherus BioSciences (CHRS) Reports Q1 Loss, Lags Revenue Estimates
Other News for BRTX
BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference ...
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 ...
BioRestorative Therapies (BRTX) Initiates $2 Million Stock Buyback Program | BRTX Stock News
BioRestorative Announces Share Repurchase Program | BRTX Stock News
BioRestorative Therapies announces share repurchase program; shares gain over 8%